Chemotherapy is the primary treatment for non-Hodgkin lymphoma, though people may also receive it with immunotherapy. Chemotherapy remains the first-line treatment for non-Hodgkin lymphoma (NHL), a ...

Cardiovascular and hematologic complications of Hodgkin vs non-Hodgkin lymphoma and readmission trends: A National Readmission Database analysis from years 2016-2020. Real-world cost of disease ...

Incyte INCY announced positive top-line results from a late-stage lymphoma study of Monjuvi/Minjuvi (tafasitamab), a ...

Leveraging Implementation Science to Optimize Strategies for Cancer Control in Mexico and Latin America We enrolled 55 patients with low grade lymphoma. Median age was 58 (range 28-82), 35 (64%) were ...

Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate. The potential Food and Drug ...

After a 4 Gy dose of radiotherapy in two fractions, 20 of 24 patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma had complete responses. The four patients with residual disease ...

The review summarized existing evidence around short- and long-term treatment-related toxicities among adolescents and young adults (AYAs), as well as gaps in care guidelines for AYA survivors of ...

Please provide your email address to receive an email when new articles are posted on . The addition of tafasitamab-cxix to lenalidomide and rituximab improved outcomes for patients with relapsed or ...

Primary thyroid lymphoma (PTL) is an uncommon thyroid malignancy, representing approximately 1–5% of thyroid cancers and 2.5–7% of extranodal lymphomas. Predominantly of B‐cell origin, PTL most ...

Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions. Dr. Andre Henri Goy of John Theurer Cancer ...

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a ...